TITLE

Predictors and prevention of diabetic cardiomyopathy

AUTHOR(S)
Chavali, Vishalakshi; Tyagi, Suresh C.; Mishra, Paras K.
PUB. DATE
April 2013
SOURCE
Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy;Apr2013, Vol. 6, p151
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Despite our cognizance that diabetes can enhance the chances of heart failure, causes multiorgan failure,and contributes to morbidity and mortality, it is rapidly increasing menace worldwide. Less attention has been paid to alert prediabetics through determining the comprehensive predictors of diabetic cardiomyopathy (DCM) and ameliorating DCM using novel approaches. DCM is recognized as asymptomatic progressing structural and functional remodeling in the heart of diabetics, in the absence of coronary atherosclerosis and hypertension. The three major stages of DCM are: (1) early stage, where cellular and metabolic changes occur without obvious systolic dysfunction; (2) middle stage, which is characterized by increased apoptosis, a slight increase in left ventricular size, and diastolic dysfunction and where ejection fraction (EF) is ,50%; and (3) late stage, which is characterized by alteration in microvasculature compliance, an increase in left ventricular size, and a decrease in cardiac performance leading to heart failure. Recent investigations have revealed that DCM is multifactorial in nature and cellular, molecular, and metabolic perturbations predisposed and contributed to DCM. Differential expression of microRNA (miRNA), signaling molecules involved in glucose metabolism, hyperlipidemia, advanced glycogen end products, cardiac extracellular matrix remodeling, and alteration in survival and differentiation of resident cardiac stem cells are manifested in DCM. A sedentary lifestyle and high fat diet causes obesity and this leads to type 2 diabetes and DCM. However, exercise training improves insulin sensitivity, contractility of cardiomyocytes, and cardiac performance in type 2 diabetes. These findings provide new clues to diagnose and mitigate DCM. This review embodies developments in the field of DCM with the aim of elucidating the future perspectives of predictors and prevention of DCM.
ACCESSION #
87491252

 

Related Articles

  • Depression and Insulin Resistance in Non-Diabetic Subjects: An Intervention Study with Insulin Clamp Technique. Asghar, Shaheen; Magnusson, A.; Hussain, Akhtar; Diep, Lien M.; Bhowmik, Bishwajit; Thorsby, Per M. // International Journal of Clinical Medicine;Dec2012, Vol. 3 Issue 7, p575 

    Aims: To clarify the relationship between depression and glucose metabolism using sensitive measures of insulin resistance, and to assess if remission of depression results in enhanced insulin sensitivity. Methods: An intervention study to quantify changes in insulin sensitivity before and after...

  • microRNA in the development of diabetic complications. MCCLELLAND, Aaron D.; KANTHARIDIS, Phillip // Clinical Science;Jan2014, Vol. 126 Issue 2, p95 

    Today's world population is currently faced with a new type of non-transmissible pandemic: obesity. This lifestyle-related condition is driving the emergence of the diabetes pandemic through the development of low-level chronic inflammation. In recent years, a novel class of non-coding RNA,...

  • Long-term exposure to nonylphenol affects insulin signaling in the liver of adult male rats. Jubendradass, R; D’Cruz, SC; Mathur, PP // Human & Experimental Toxicology;Sep2012, Vol. 31 Issue 9, p868 

    In the present study, we sought to investigate the long-term effects of nonylphenol (NP) on insulin signaling and glucose metabolism in liver. Furthermore, reactive oxygen species (ROS) in liver was evaluated as it is known to induce insulin resistance. Rats were administered NP by oral gavage...

  • Serum Visfatin Levels, Adiposity and Glucose Metabolism in Obese Adolescents. Taşkesen, Derya; Kirel, Birgül; Us, Tercan // Journal of Clinical Research in Pediatric Endocrinology;Jun2012, Vol. 4 Issue 2, p76 

    Objective: Visfatin, an adipokine, has insulin-mimetic effects. The main determinants of both the production and the physiologic role of visfatin are still unclear. The aim of this study is to determine the relation of serum visfatin to adiposity and glucose metabolism. Methods: 40 pubertal...

  • Fatal Congenital Hypertrophic Cardiomyopathy and a Pancreatic Nodule Morphologically Identical to Focal Lesion of Congenital Hyperinsulinism in an Infant with Costello Syndrome: Case Report and Review of the Literature. SHEFFIELD, BRANDON S.; YIP, STEPHEN; RUCHELLI, EDUARDO D.; DUNHAM, CHRISTOPHER P.; SHERWIN, ELIZABETH; BROOKS, PAUL A.; SUR, AMITAVA; SINGH, AVASH; HUMAN, DEREK G.; PATEL, MILLAN S.; LEE, ANNA F. // Pediatric & Developmental Pathology;May/Jun2015, Vol. 18 Issue 3, p237 

    Costello syndrome is characterized by constitutional mutations in the proto-oncogene HRAS, causing dysmorphic features, multiple cardiac problems, intellectual disability, and an increased risk of neoplasia. We report a male infant with dysmorphic features, born prematurely at 32 weeks, who,...

  • Stress Hyperglycemia, Insulin Treatment, and Innate Immune Cells. Fangming Xiu; Stanojcic, Mile; Li Diao; Jeschke, Marc G. // International Journal of Endocrinology;2014, p1 

    Hyperglycemia (HG) and insulin resistance are the hallmarks of a profoundly altered metabolism in critical illness resulting from the release of cortisol, catecholamines, and cytokines, as well as glucagon and growth hormone. Recent studies have proposed a fundamental role of the immune system...

  • Islet Transplantation Stabilizes Hemostatic Abnormalities and Cerebral Metabolism in Individuals With Type 1 Diabetes. D'Addio, Francesca; Maffi, Paola; Vezzulli, Paolo; Vergani, Andrea; Mello, Alessandra; Bassi, Roberto; Nano, Rita; Falautano, Monica; Coppi, Elisabetta; Finzi, Giovanna; D'Angelo, Armando; Fermo, Isabella; Pellegatta, Fabio; Rosa, Stefano La; Magnani, Giuseppe; Piemonti, Lorenzo; Falini, Andrea; Folli, Franco; Secchi, Antonio; Fiorina, Paolo // Diabetes Care;Jan2014, Vol. 37 Issue 1, p267 

    OBJECTIVE Islets after kidney transplantation have been shown to positively affect the quality of life of individuals with type 1 diabetes (T1D) by reducing the burden of diabetes complications, but fewer data are available for islet transplantation alone (ITA). The aim of this study was to...

  • RELATIONSHIP BETWEEN INSULIN RESISTANCE AND.  // Heart;Oct2010 Supplement, pA125 

    An abstract of the article " Relationship Between Insulin Resistance and" by Wei Ren-long, Hasimu Buaijiaer, Yuan Bin-bin and Yang Zhi-jian is presented.

  • Insulin resistance model. O'Connor, Patrick G.; Berkowitz, Henry D.; Cohn, Peter F.; Gorman, B. David; Lief, Philip D.; Mishell Jr., Daniel R.; Nichols, Gwen L.; Rigsby, Michael O.; Ryan, Michael E. // Cortlandt Forum;12/20/97, Vol. 10 Issue 12, p81 

    Features an insulin resistance model. Reason why tissues receiving too much glucose develop insulin resistance.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics